Latest News About - Strongyloidiasis

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Tuesday, July 27, 2021

5:18:00 PM CEST

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ab
ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
my
ne
nl
no
os
pap
pl
ps
pt
ro
ru
se
si
sk
sl
so
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Most reported countries (24h)

Theme countries

AlertLevel (24h)

Alert level graph

 Previous 14 days average

Alert level:
 high   medium   low

Quotes... Extracted quotes

Christopher Tufton told: “The drug is used for parasitic treatment and the advisory of the ministry remains that there is no evidence that it will benefit COVID-19 patients,” External link

jamaicaobserver Tuesday, July 27, 2021 12:10:00 AM CEST

Derek Lowe said: “I do not think that the current evidence is strong enough to say that Ivermectin is a useful therapy for coronavirus patients,” External link

zimbabwesituation Saturday, July 24, 2021 7:52:00 AM CEST

Derek Lowe said: “I do not think that the current evidence is strong enough to say that Ivermectin is a useful therapy for coronavirus patients,” External link

newsday Saturday, July 24, 2021 12:22:00 AM CEST

Dumelang Saleshando told: “Since the outbreak of Covid 19, there has been debate on the medical use of Ivermectin for Covid-19 patients. Experts in countries like the United Kingdom, Italy, Spain and Japan have published reports that show how the drug significantly reduces mortality. An increasing number of countries are approving the use of the drug for Covid patients, including South Africa and Zimbabwe. Why is Botswana not considering the use of the drug given the uncontrollable increase in infection,” External link

sundaystandard Tuesday, July 20, 2021 11:12:00 AM CEST

Bernard Haufiku said: “Both studies stated that there is no difference between the standard care of getting inflammatory medication or taking Panado. There is no difference between the type of approach to a patient with mild to moderate Covid than giving ivermectin,” External link

namibian Tuesday, June 22, 2021 12:29:00 AM CEST

Bernard Haufiku said: “WHO says we can only use ivermectin on controlled trials. And I suggested that as well, that we must set up a cohort with a few patients who can volunteer to be on ivermectin and then we observe them for a period much longer than what has happened in the past,” External link

namibian Tuesday, June 22, 2021 12:29:00 AM CEST

Daily number of articles in this category

Trend data not available for this selection.